Archived Seminar: Sex, Drugs and Radiomics of Brain Cancer
Pioneers in Biomedical Research Seminar presented by the Fralin Biomedical Research Institute at VTC
About this Seminar
Glioblastoma are notoriously aggressive, malignant primary brain tumors that have variable response to treatment. This presentation will focus on the integrative role of 1) biological sex-differences, 2) heterogeneity in drug-delivery and 3) intra-tumoral molecular diversity (revealed by radiomics) in capturing and predicting this variable response to treatment. Specifically, Dr. Swanson will highlight burgeoning insights into sex differences in tumor incidence, outcomes, propensity and response to therapy. She will further quantify the degree to which heterogeneity in drug delivery, even for drugs that are able to bypass the blood-brain barrier, contributes to differences in treatment response. Lastly, she will propose an integrative role for spatially resolved MRI-based radiomics models to reveal the intra-tumoral biological heterogeneity that can be used to guide treatment targeting and management.
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Cancer Research Group. The Fralin Biomedical Research Institute Pioneers in Biomedical Research Program offers the expertise of a range of scientists who are exploring frontiers in biomedical research. These seminars are open to Virginia Tech and Carilion Clinic faculty, students, and staff.
You May Also Be Interested In...
Home ItemCANCELLED: In Person Seminar: A Novel Metabolic-Epigenetic Axis in Vascular Remodeling Processes , home
CANCELLED: Feb. 3, 2023, 11 a.m. | Sébastien Bonnet, Ph.D., Professor, Department of Medicine, Director, Canadian Research Chair in Translational Research in Pulmonary and Vascular Diseases, Director, Pulmonary Hypertension Research Group, University of Laval | Pioneers in Biomedical Research Seminar Series | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research
Home ItemIn Person Lecture: Achieving Cancer Health Equity – A Model of Integrating Research, Advocacy and Policy for Colorectal Cancer , home
Feb. 3, 2023, 1 p.m. | Chyke Doubeni, M.B.B.S., M.P.H., Professor and Chief Health Equity Officer, Wexner Medical Center, The Ohio State University | Timothy A. Johnson Medical Scholar Lecture Series
Home ItemSeminar: Integrated Bioelectronic Systems for Biomedical Research and Healthcare: Materials, Electronics, and Computing , home
Feb. 7, 2023, 12 p.m. | Wei Ouyang, Ph.D., Postdoctoral Fellow, Querrey Simpson Institute for Bioelectronics, Northwestern University | Seminar
Home ItemSeminar: Molecular Targets of Prenatal Alcohol Exposure During Early Brain Development , home
Feb. 8, 2023, 2 p.m. | Karen Boschen, Ph.D., Postdoctoral Research Associate, Bowles Center for Alcohol Studies, University of North Carolina School of Medicine | Seminar
Home ItemIn Person Lecture: Developmental Cognitive Neuroscience in the Era of Big Data , home
Feb. 9, 2023, 5:30 p.m. (Reception at 5 p.m.) | Damien Fair, PA-C, Ph.D., Professor, Institute of Child Development, Department of Pediatrics, College of Education and Human Development, University of Minnesota Medical School | Maury Strauss Distinguished Public Lecture
Kristin R. Swanson, Ph.D.
The Vasek and Anna Maria Polak Professor in Cancer Research; Professor of Neurological Surgery, Molecular Neuroscience, and Radiation Oncology; Mayo Clinic, Phoenix, Arizona